
OniX helps biotech startups, universities, and pharma partners find and connect biomedical ideas and assets to speed therapies. The platform uses artificial intelligence, machine learning, natural language processing, and cognitive computing to analyze over 1 million assets from 100,000+ companies and 5,000+ universities. As a SaaS subscription, it enables strategic partnerships, due diligence, and competitive intelligence. It surfaces drug targets and assets and facilitates connections to researchers, KOLs, and potential investors. This approach broadens access to biomedical data and supports collaboration across biotech, pharmaceutical, and academic ecosystems at scale.

OniX helps biotech startups, universities, and pharma partners find and connect biomedical ideas and assets to speed therapies. The platform uses artificial intelligence, machine learning, natural language processing, and cognitive computing to analyze over 1 million assets from 100,000+ companies and 5,000+ universities. As a SaaS subscription, it enables strategic partnerships, due diligence, and competitive intelligence. It surfaces drug targets and assets and facilitates connections to researchers, KOLs, and potential investors. This approach broadens access to biomedical data and supports collaboration across biotech, pharmaceutical, and academic ecosystems at scale.